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ABSTRACT The intracellular protozoan parasite Toxoplasma gondii is capable of infecting most nucleated cells, where it survives in a specially modiﬁed compartment called
the parasitophorous vacuole (PV). Interferon gamma (IFN-␥) is the major cytokine involved in activating cell-autonomous immune responses to inhibit parasite growth
within this intracellular niche. In HeLa cells, IFN-␥ treatment leads to ubiquitination of
susceptible parasite strains, recruitment of the adaptors p62 and NDP52, and engulfment in microtubule-associated protein 1 light chain 3 (LC3)-positive membranes that
restrict parasite growth. IFN-␥-mediated growth restriction depends on core members of
the autophagy (ATG) pathway but not the initiation or degradative steps in the process.
To explore the connection between these different pathways, we used permissive biotin
ligation to identify proteins that interact with ATG5 in an IFN-␥-dependent fashion. Network analysis of the ATG5 interactome identiﬁed interferon-stimulated gene 15 (ISG15),
which is highly upregulated by IFN treatment, as a hub connecting the ATG complex
with other IFN-␥-induced genes, suggesting that it forms a functional link between the
pathways. Deletion of ISG15 resulted in impaired recruitment of p62, NDP52, and LC3 to
the PV and loss of IFN-␥-restricted parasite growth. The function of ISG15 required conjugation, and a number of ISGylated targets overlapped with the IFN-␥-dependent ATG5
interactome, including the adapter p62. Collectively, our ﬁndings establish a role for
ISG15 in connecting the ATG pathway with IFN-␥-dependent restriction of T. gondii in
human cells.
IMPORTANCE Interferon(s) provide the primary defense against intracellular pathogens,

a property ascribed to their ability to upregulate interferon-stimulated genes. Due to the
sequestered niche occupied by Toxoplasma gondii, the host has elaborated intricate
ways to target the parasite within its vacuole. One such mechanism is the recognition
by a noncanonical autophagy pathway that envelops the parasite-containing vacuole
and stunts growth in human cells. Remarkably, autophagy-dependent growth restriction
requires interferon-␥, yet none of the classical components of autophagy are induced by
interferon. Our studies draw a connection between these pathways by demonstrating
that the antiviral protein ISG15, which is normally upregulated by interferons, links the
autophagy-mediated control to ubiquitination of the vacuole. These ﬁndings suggest a
similar link between interferon-␥ signaling and autophagy that may underlie defense
against other intracellular pathogens.
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he apicomplexan Toxoplasma gondii is a common parasite of warm-blooded animals that also causes zoonotic infections in humans, most importantly due to
congenital transmission or opportunistic infections in immunocompromised patients
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(1). The parasite resides within the parasitophorous vacuole (PV), which is formed by
invagination of the plasma membrane during active invasion of the parasite, and this
unique intracellular niche is critical to avoidance of lysosomal fusion and survival (2).
Strains of T. gondii comprise three predominant lineages that are common in North
America and Europe (3). Type I strains are rare in humans but highly virulent in mice,
type II strains are of intermediate virulence in mice and the most common in human
infection, and type III strains are avirulent in mice and common in domestic animals but
very rare in humans (3). Control of T. gondii infection is dependent on interferon
gamma (IFN-␥) signaling in both murine (4, 5) and human cells (6, 7), although the
mechanisms differ between species and cell types.
In murine cells, stimulation with IFN-␥ results in upregulation of a variety of
interferon-stimulated genes (ISGs), including immunity-related GTPases (IRGs) and
guanylate binding proteins (GBPs) that play important roles in host defense (8, 9).
Recruitment of IRGs (10, 11) and GBPs (12–14) to PVs surrounding susceptible parasite
strains results in vesiculation of the PV membrane and destruction of the parasite. Type
I strains, which are highly virulent in laboratory mice, largely avoid this fate, while types
II and III are highly susceptible (15). These pathways are counteracted by secretion of
a parasite family of polymorphic ROP kinases that target IRGs and GBPs to prevent
their accumulation on the PV, thus protecting this intracellular niche (15, 16). The
IRG family has undergone expansion and selection for polymorphism in mice, where
they play a major role in host defense; however, they are largely absent in human
cells (17). As such, human cells rely on overlapping and distinct pathways for
IFN-␥-dependent control of parasite replication, including depletion of tryptophan
via indoleamine 2,3-dioxygenase, select GBPs, generation of reactive oxygen species, ubiquitination, and lysosomal clearance (18).
One IFN-␥-dependent control mechanism that is shared between murine and
human cells is involvement of proteins in the autophagy (ATG) pathway, which is
normally involved in cellular remodeling and nutrient recycling but also plays important roles in host defense (19). Core components of the ATG pathway that are involved
in lipidation and recruitment of microtubule-associated protein 1 light chain 3 (LC3) are
required for control of T. gondii infection in IFN-␥-treated murine and human cells (18).
Key members of this pathway include the ATG5-12-16L1 complex, as well as ATG3 and
ATG7, which are required for recruitment of IRGs and vesiculation of the PV in murine
cells activated with IFN-␥ (20, 21). This complex of ATG proteins may be directly
involved in the recruitment of IRGs to the PV (20) or, alternatively, be required for
homeostasis of the IRG system (21). The upstream initiation steps (i.e., ATG14 and
Beclin) and downstream degradative steps (i.e., lysosome fusion) of the ATG pathway
are not required for control of T. gondii infection in murine cells (20, 21). IFN-␥-mediated
control of T. gondii in human HeLa cells requires a similar complex of ATG proteins,
including ATG5 and ATG7 (22). However, unlike the murine system, engagement of this
pathway does not lead to PV vesiculation in human cells. Rather, recruitment of LC3 to
PVs containing susceptible strains of T. gondii results in formation of multiple membranes around PV and stunted parasite growth (22). Similar to murine cells, type I
strains are largely resistant to ATG-dependent growth inhibition, while types II and III
are susceptible to this pathway (22). The ﬁrst step in this pathway is ubiquitination (Ub)
of the PV, followed by recruitment of adaptors p62 and NDP52 and decoration by LC3B
(22). Similar to the murine system, this process requires ATG16L1 and ATG7 but is
independent of ATG14 and Beclin (22). In this regard, the ATG-dependent pathway for
restriction of T. gondii growth in human cells resembles xenophagy (23), with the
exceptions that the former is IFN-␥ dependent and it does not lead to lysosomal fusion
in HeLa cells. Separately, it was described that IFN-␥ activation of HUVEC cells, a human
endothelial cell line, leads to ubiquitination, recruitment of p62 and NDP52, fusion with
lysosomes, and destruction in a process that is not dependent on ATG16L1. This
difference in reliance on ATG proteins likely reﬂects differences in the mechanisms of
cell-autonomous immunity between different human cell types (24).
IFN-␥ signaling activates cell-autonomous immunity by upregulating interferonmbio.asm.org 2
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stimulated genes (ISGs) to counteract intracellular pathogens (9, 25, 26). Although
many genes are upregulated by IFN-␥, ATG proteins are not typically among them.
Hence, the link between the IFN-␥-dependent cell-autonomous control of pathogens
and ATG pathways is unclear. IFN-␥ upregulates the expression of another ubiquitinligase-related system in cells that depends on the protein interferon-stimulated gene
15 (ISG15) (27). ISG15 forms covalent and noncovalent interactions with host cellular
proteins and governs diverse cellular pathways, including host defense and autophagy
(28). Previously published studies have largely focused on type I IFN-dependent protein
ISGylation during viral infection (29). However, a recent study has shown that free ISG15
is important for recruitment of interleukin-1␤ (IL-1␤)-producing dendritic cells at the
site of T. gondii infection in mice (30). The role of ISG15 has not been examined in
human cells infected with T. gondii.
Here, we were interested in identifying the connection between the ATG pathway
and IFN-␥ signaling that leads to control of T. gondii infection in human cells. We found
that ISG15 functioned by governing IFN-␥-dependent recruitment of ATG mediators to
PVs occupied by intracellular T. gondii. Hence, ISG15 forms an important molecular link
between the ATG and IFN-␥ signaling pathways to enable cell-autonomous host
defense in human cells.
RESULTS
Identiﬁcation of IFN-␥-dependent interactors of ATG5 by proximity-based
biotin labeling. To explore the role of ATG in IFN-mediated control of intracellular
parasite growth, we examined proteins that interact with ATG5 in an IFN-␥-dependent
fashion using proximity-based biotin labeling. For this purpose, we generated a stable
line of HeLa cells expressing ATG5 with the permissive biotin ligase BirA (31) fused to
its N terminus, referred to as BirA-ATG5. We stimulated HeLa cells expressing BirA-ATG5
with IFN-␥ followed by addition of biotin in the medium and afﬁnity puriﬁcation of the
biotinylated proteins using streptavidin beads (Fig. 1A). Immunoblotting of the immunoprecipitated proteins with streptavidin revealed a number of endogenous proteins
that were labeled in the absence of added biotin, consistent with previous reports of
host proteins that are normally biotinylated in human cells (32) (Fig. 1B).
We next compared proteomic proﬁles generated by label-free mass spectrometry of
IFN-␥-stimulated samples with unstimulated samples, grown in the presence of biotin.
Samples were repeated in four separate experiments, and the combined data were
used to analyze the interactome of ATG5. In order to identify IFN-␥-dependent ATG5
interactors, we selected proteins on the basis of peptide count (ⱖ2 peptides in the
average of 4 replicates) and fold change in normalized weighted spectra (ⱖ2 in
IFN-␥-stimulated versus unstimulated control samples) (Table 1). We also included the
autophagy proteins (SQSTM1, ATG12, ATG16L1, ATG3, and ATG2B), as they are essential
for the autophagy pathway (19). The ﬁnal IFN-␥-dependent ATG5 interactome comprised 40 proteins (Table 1). We identiﬁed 87 interactors of ATG5 in naive HeLa cells and
40 interactors that were enhanced in IFN-␥-stimulated HeLa cells using permissive
biotin labeling. Previously, Behrends et al. (33) identiﬁed 142 interactors of HA-tagged
ATG5 by immunoprecipitation in HEK293T cells; however, they only considered four of
these to be high-conﬁdence interactors. Comparison of the 4 high-conﬁdence interactors (i.e., ATG16L1, TECPR1, TKT, and ATG12) showed that 3 of these proteins (i.e.,
ATG16L1, ATG12, and TECPR1) overlapped with our list of ATG5 interactors in naive
cells, and 2 (i.e., ATG16L1 and ATG12) of these overlapped with our list of IFN-␥stimulated interactors in HeLa cells. The differences in proteins detected by these two
methods likely represent a combination of cell types, experimental approaches, and
criteria for classifying meaningful interactions.
To visualize the interactome, we analyzed the resulting list using the STRING
database (version 10.5), which builds protein-protein interactions based on experimental evidence and predictions based on genomic context (34). As expected, the ATG
proteins, including the adaptor SQSTM1 (also known as p62), which is responsible for
cargo recognition, and components involved in autophagosome formation and closure
September/October 2020 Volume 11 Issue 5 e00852-20
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FIG 1 Identiﬁcation of ATG5 interacting proteins by permissive biotin ligase labeling. (A) Experimental design for identiﬁcation of ATG5 interactors by
proximity-based biotin labeling. HeLa cells expressing an N-terminal fusion with permissive biotin ligase BirA were treated with or without IFN-␥ (100

(Continued on next page)
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TABLE 1 IFN-␥-dependent ATG5 interactome identiﬁed by proximity labeling
Gene name
WARS
STAT1
ISG15
RNF213
HSD17B10
TAP1
HLA-A
FLG
HIST1H4A
S100A9
PGK1
ZC3HAV1
TJP1
GBP1
IFIT5
ETFA
SRRM2
PFN1
MTHFD1L
SAMHD1
DHX15
CSRP1
LUZP1
VPS13C
RPL6
RPL23A
STAT3
AKAP2
RPS4X
DHX9
UTRN
LDHA
LMNA
ALDOA
TTC28
SQSTM1
ATG12
ATG16L1
ATG3
ATG2B

Fold
changea
24
15
6.6
4.1
4
3.7
3.7
3.6
3.3
3.3
3
3
2.9
2.9
2.7
2.6
2.6
2.5
2.4
2.3
2.2
2.2
2.2
2.1
2.1
2.1
2.1
2.2
2.1
2.2
2
2
2
2
2
1.4
1.3
1
0.9
0.8

Naive replicatesb
4
6
2
1
4
8
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
3
1
1
4
3
1
3
1
1
4
2
1
1
4
6
1
3
3
1
1
2
1
1
1
5
1
2
1
1
1
1
1
1
1
1
1
1
1
2
1
1
1
1
1
3
1
1
1
1
1
1
1
1
1
1
3
1
1
1
4
2
2
2
1
3
1
1
9
17
1
1
3
1
3
1
3
2
1
1
1
7
1
1
1
3
1
1
3
1
1
1
1
3
1
1
39
42
6
11
4
10
4
2
1
1
5
3
1
2
5
1
1
3
1
1
13
5
2
2
7
3
2
1
19
17
6
12
4
5
2
4
1
2
1
1

IFN-␥-stimulated
replicatesb
67
91
85
54
87
22
13
8
1
3
9
1
1
1
1
5
5
3
4
11
4
10
2
21
1
1
14
15
1
4
1
15
5
3
8
1
5
14
1
1
6
1
2
6
1
1
2
1
2
8
1
2
12
1
1
1
1
1
6
1
7
5
1
8
5
4
5
8
1
18
28
1
1
6
6
3
5
1
8
11
1
3
9
1
8
2
1
1
8
1
70
81
15
2
25
5
1
6
8
1
7
8
2
9
1
18
7
3
8
4
1
18
19
10
3
5
1
1
1
1

72
46
4
3
13
2
4
11
9
20
4
4
7
4
2
9
1
3
7
1
1
6
1
11
4
6
2
1
1
4
30
9
5
2
1
1
4
8
4
1

change in normalized weighted spectra in IFN-␥-stimulated versus unstimulated samples. The criteria for inclusion are (i) ⱖ2 peptides in the average of 4
replicates and (ii) ⱖ2-fold increase in IFN-␥-stimulated versus unstimulated control samples.
bReplicates wherein columns represent normalized weighted spectra.
aFold

(i.e., ATG2B, ATG3, ATG5, ATG12, and ATG16L1) (35, 36), formed a tightly interacting
cluster (Fig. 1C). ISG15 formed a central hub in the network (Fig. 1C). ISG15 showed high
fold change with IFN-␥ treatment (6.6-fold increase) and interacted directly with ATG5,
ATG12, ATG3, and SQSTM1 (evidence from text mining and experimental data) (Fig. 1C)
(37). Based on multiple lines of evidence, ISG15 also makes connections with the
proteins GBP1, STAT1, and STAT3, which are known to play important roles during T.
gondii infection (Fig. 1C) (38). The STAT1 cluster also included WARS and IFTI5, which
are known to be upregulated by IFN-␥ (39, 40) and augment antiviral host defense (41,

FIG 1 Legend (Continued)
U/ml) for 24 h. Following stimulation, cells were grown in the presence of biotin (150 M) for 18 h, lysed in detergent, and afﬁnity puriﬁed using
streptavidin beads. (B) Biotinylated proteins in cell lysates and washed beads from the experimental set up in panel A were detected by Western blotting
with IRDye 800CW-labeled (green) streptavidin. The lysate blot was imaged at intensity 4, and the washed bead blot was imaged at intensity 7. (C)
Network of the ATG5 interactome using the STRING database. Proteins identiﬁed by mass spectrometry were analyzed using Scaffold version 4.0. The
normalized weighted spectra of IFN-␥-stimulated samples were compared with unstimulated samples that were both grown in the presence of biotin.
Proteins showing enrichment (see Table 1) are represented by nodes (ﬁlled circles) in the network, and the edges indicate interactions. Criteria for
interactions are shown by colored lines as follows: red line, gene fusion events; green line, gene neighborhood; blue line, gene cooccurrence; purple
line, experimental evidence; yellow line, text mining; light blue line, database; black line, coexpression.
September/October 2020 Volume 11 Issue 5 e00852-20
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Identiﬁed proteins
Tryptophan-tRNA ligase, cytoplasmic
Cluster of signal transducer and activator of transcription 1-alpha/beta
Ubiquitin-like protein ISG15
E3 ubiquitin-protein ligase RNF213
3-hydroxyacyl-CoA dehydrogenase type-2
Antigen peptide transporter 1
Cluster of HLA class I histocompatibility antigen, A-68 alpha chain
Filaggrin
Histone H4
Protein S100-A9
Phosphoglycerate kinase 1
Zinc ﬁnger CCCH-type antiviral protein 1
Tight junction protein ZO-1
Cluster of guanylate-binding protein 1
Interferon-induced protein with tetratricopeptide repeats 5
Electron transfer ﬂavoprotein subunit alpha, mitochondrial
Serine/arginine repetitive matrix protein 2
Proﬁlin-1
Monofunctional C1-tetrahydrofolate synthase, mitochondrial
Deoxynucleoside triphosphate triphosphohydrolase SAMHD1
Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15
Cysteine and glycine-rich protein 1
Leucine zipper protein 1
Vacuolar protein sorting-associated protein 13C
60S ribosomal protein L6
60S ribosomal protein L23a
Signal transducer and activator of transcription 3
A-kinase anchor protein 2
40S ribosomal protein S4, X isoform
ATP-dependent RNA helicase A
Utrophin
L-lactate dehydrogenase A chain
Prelamin-A/C
Fructose-bisphosphate aldolase A
Tetratricopeptide repeat protein 28
Sequestosome-1
Ubiquitin-like protein ATG12
Autophagy-related protein 16-1
Ubiquitin-like-conjugating enzyme ATG3
Autophagy-related protein 2 homolog B
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FIG 2 IFN-␥ stimulation induces ISG15 expression and ISGylation in human cells. (A) Wild-type (WT) and
ATG16L1 knockout (KO) HeLa cells were grown in ⫾ IFN-␥ (100 U/ml) for 24 h. Cell lysates were prepared
and equal amounts of protein were loaded for immunoblotting. ISG15 expression (⬃17 kDa) and protein
ISGylation (higher-molecular-weight bands) were detected using rabbit polyclonal ISG15 antibody and
LI-COR IRDye 800CW (green) goat anti-rabbit IgG. As a loading control, a parallel blot was probed with
mouse monoclonal actin antibody (43 kDa) and LI-COR IRDye 680CW (red) goat anti-mouse IgG. (B)
Wild-type (WT) and ISG15 knockout (KO) A549 cells were grown in ⫾ IFN-␥ (100 U/ml) for 24 h. Cell
lysates were prepared and equal amounts of protein were loaded for immunoblotting. ISG15 expression
and protein ISGylation were detected using rabbit polyclonal ISG15 antibody and LI-COR IRDye 800CW
(green) goat anti-rabbit IgG. As a loading control a parallel blot was probed with mouse monoclonal actin
antibody and LI-COR IRDye 800CW (green) goat anti-mouse IgG. Both wild-type and ISG15 KO cells
showed low levels of cross-reactivity to anti-ISG15 by Western blotting (i.e., band around 35 kDa).

42) (Fig. 1B). ISG15 also interacted with SAMHD1, which is induced by IFNs and has
antiviral function (43). S100A9, which is known to be upregulated during infection and
inﬂammation (44), was also present in the ATG5 interactome. IFN-␥ is associated with
metabolic reprogramming, and enzymes of the glycolytic pathway (i.e., PGK1, ALDOA,
and LDHA) formed a separate cluster of the ATG5 interactome (Table 1, Fig. 1C) (45).
The ribosomal protein cluster consisting of RPS4X, RPL23A, and RPL6 interacted with
other protein clusters via ISG15 and also with a cluster enriched in proteins implicated
in viral RNA sensing, DHX9 and DHX15 (46) (Fig. 1C).The network also contained several
mitochondrial proteins (i.e., ETFA, HSD17B10, and MTHFD1L) and transport proteins
such as VPS13C, which has been implicated in mitophagy (47). Based on the central
position of ISG15 in the ATG5 interactome, we decided to focus on this protein, which
plays important roles in antiviral defense (48) but has not previously been implicated
in cell-autonomous control of T. gondii.
IFN-␥ stimulation induces ISG15 expression and ISGylation in human cells. We
observed a high fold change for interaction of ATG5 with ISG15 in IFN-␥-treated
samples (Table 1). This prompted us to study the effect of IFN-␥ on ISG15 induction and
ISGylation of cellular proteins in HeLa (cervical) and A549 (lung) cells. Both cell types are
human epithelial in origin, and as shown below, the ATG-dependent control of T. gondii
growth previously described in HeLA cells also extends to A549 cells. We observed that
in the absence of IFN-␥, HeLa cells expressed low levels of ISG15, and stimulation with
IFN-␥ enhanced ISG15 levels (Fig. 2A). Addition of IFN-␥ also led to ISGylation of cellular
proteins that were detected as a high-molecular-weight smear, while these highmolecular-weight ISG15 conjugates were absent in unstimulated samples (Fig. 2A). The
ATG5 interactome showed an interaction between ISG15 and the ATG protein cluster,
suggesting that ATG proteins may affect ISG15 expression and ISGylation. To examine
the role of ATG in IFN-␥-dependent ISG15 expression and conjugate formation, we used
HeLa cells lacking the key ATG protein ATG16L1 (Fig. 2A). We observed that the absence
of ATG16L1 in HeLa cells did not affect IFN-␥-dependent ISG15 expression or ISGylation
of cellular proteins (Fig. 2A). We also observed a similar upregulation of ISG15 and
ISGylation in A549 cells in response to IFN-␥ treatment (Fig. 2B).
ISG15 does not impact ubiquitination of the PV but is important for recruitment of p62, NDP52, and LC3. To examine the role of ISG15 in ATG-dependent
control of T. gondii in IFN-␥ treated cells, we examined ubiquitination and recruitment
September/October 2020 Volume 11 Issue 5 e00852-20
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FIG 3 Role of ISG15 in IFN-␥ dependent recruitment of autophagy mediators. Wild-type (WT) and ISG15
knockout (KO) A549 cells were grown with or without IFN-␥ (100 U/ml) for 24 h. Cells were infected with
type III T. gondii CTG strain tachyzoites and washed 2 h postinfection. (A to H) Recruitment of autophagy
mediators as indicated by percentage of PV positive for (A and B) ubiquitin (Ub), (C and D) p62, (E and
F) NDP52, and (G and H) LC3 was determined 6 h postinfection by immunofluorescence microscopy. The
values represent means ⫾ standard error from three independent experiments, each containing three
internal replicates. Two-way ANOVA was used to determine statistical signiﬁcance. P values of ⱕ0.05 (*),
ⱕ0.01 (**), ⱕ0.001 (***), and ⱕ0.0001 (****) were considered statistically signiﬁcant. ns, not signiﬁcant.
Representative images showing recruitment are on the right. Arrows indicate positive recruitment. Scale
bar ⫽ 5 m. Parasites (red) were identiﬁed by SAG1 (mouse monoclonal DG52 antibody) or tachyzoite
(rabbit polyclonal anti-whole tachyzoite antibody) staining, followed by secondary antibodies conjugated to Alexa Fluor 594 (red) conjugated goat anti-mouse IgG or goat anti-rabbit IgG. Autophagy
mediators (green) were stained with mouse monoclonal ubiquitin antibody, guinea pig polyclonal p62
antibody, rabbit polyclonal NDP52 antibody, rabbit polyclonal LC3 antibody followed by Alexa Fluor 488
(green) conjugated goat anti mouse IgG, guinea pig IgG, or rabbit IgG. Nuclei were stained with DAPI
(4=,6-diamidino-2-phenylindole) (blue).

of autophagy mediators (i.e., p62, NDP52, and LC3) to the PV. Given the similar response
of HeLa and A549 cells to IFN-␥, to ISG15 induction, and to protein ISGylation, we took
advantage of existing wild-type and knockout (KO) lines of the human lung carcinoma
epithelial line A549 (Fig. 2A and B). Similar to our previous ﬁndings with HeLa cells,
IFN-␥ treatment led to a signiﬁcant increase in the percentage of PV that were positive
for ubiquitin (Ub) (Fig. 3A and B). The increase in ubiquitin-positive cells was similar in
ISG15 KO cells, indicating that this ﬁrst step does not rely on ISG15 (Fig. 3A and B).
Similar to previous ﬁndings in HeLa cells, recruitment of p62 to the PV in A549 cells was
September/October 2020 Volume 11 Issue 5 e00852-20
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also enhanced in the presence of IFN-␥ (Fig. 3C and D). However, in the absence of
ISG15, there were signiﬁcantly fewer p62-positive vacuoles compared to the wild-type
cells (Fig. 3C and D). We observed a similar pattern of decreased localization of the
adaptor NDP52 in ISG15 KO cells compared with wild-type cells stimulated with IFN-␥
(Fig. 3E and F). As the adaptor proteins are responsible for directing the PV to
LC3-positive autophagic membrane, we further quantiﬁed and compared the percentage of PV positive for LC3 between the two cell types (Fig. 3G and H). The number of
LC3-positive PV increased signiﬁcantly in wild-type cells in the presence of IFN-␥
(Fig. 3G and H). In ISG15 KO cells, the increase was not signiﬁcant compared to the
unstimulated control sample. The recruitment of LC3 to PV was markedly abrogated in
IFN-␥-stimulated ISG15 KO cells compared to wild-type IFN-␥-stimulated cells (Fig. 3G
and H). Costaining of ubiquitin and adaptor molecules veriﬁed that the recruitment is
sequential in A549 cells, similar to previous reports in HeLa cells (22). This conclusion
is based on the observation that there are appreciable numbers of singly ubiquitinpositive vacuoles but very few that recruit adaptors without also being ubiquitin
positive, while the majority of vacuoles are positive for both markers (Fig. S1). Moreover, in the absence of ISG15, there was an increase in singly ubiquitin-positive
vacuoles with a corresponding decrease in doubly positive vacuoles staining both with
ubiquitin and with each of the respective adaptors (Fig. S1). These data suggest that
ISG15 does not play a role in ubiquitination of PV but is important for downstream
recruitment of adaptors and LC3 to the PV.
ISG15-deﬁcient cells are not compromised in autophagy. We considered that the
impaired localization of p62, NDP52, and LC3 to the PV in the absence of ISG15 could
be due to defects in expression or reduced ﬂux through the ATG pathway. To examine
these possibilities, we stimulated wild-type and ISG15 KO cells with IFN-␥ for 24 h and
compared the levels of p62, NDP52, ATG5, and LC3 by Western blotting. We observed
that the expression levels of these proteins were comparable between wild-type and
ISG15 KO cells under resting conditions (Fig. 4A and B). Moreover, stimulation with
IFN-␥ did not affect the levels of ATG5, p62, NPD52, and LC3 proteins in either cell type
(Fig. 4A and B). Infection by T. gondii, with or without IFN-␥ treatment, also did not alter
the levels of these ATG proteins in A549 cells (Fig. S2). We next examined the induction
of autophagy by rapamycin (Rap) based on the conversion of LC3 I to LC3 II, the
lipid-conjugated and membrane-associated forms (49). Conversion to the LC3 II form
was similar in both wild-type and ISG15 KO cells treated with rapamycin, as detected
by Western blotting (Fig. 4C). We compared autophagosome formation by enumerating
LC3 puncta per cell in the presence of rapamycin (to induce autophagy) and baﬁlomycin A1 (to block lysosomal degradation). Addition of rapamycin (Rap) and baﬁlomycin A1 (Baf) led to increased LC3 puncta per cell in both wild-type and ISG15 KO cells
(Fig. 4D and E). The puncta per cell were quantiﬁed, and they were comparable
between wild-type and ISG15 KO cells in the presence of ATG modulators (Fig. 4D). We
conclude from these experiments that ISG15 KO A549 cells are not globally impaired in
autophagy.
ISG15 is important for IFN-␥-dependent restriction of T. gondii in human cells.
The studies described above indicate that ISG15 is important for recruitment of
autophagy mediators to the PV surrounding T. gondii. To determine whether ISG15
plays a functional role in this pathway, we compared the growth of T. gondii in
wild-type and ISG15 KO cells. To distinguish between conjugation-dependent and
-independent functions, we used the ubiquitin C promoter to generate complemented
wild-type ISG15 (referred to as cWT ISG15) or mutant ISG15 cell lines, which cannot be
conjugated due to mutation of critical glycine residues that are normally involved in
conjugation (50) (referred to as cISG15-AA) (Fig. 5A). Despite constitutive expression of
cWT ISG15 and cISG15-AA in complemented lines, we only observed minor ISGylation
in the absence of IFN-␥ (Fig. 5A). However, IFN-␥ treatment resulted in enhanced levels
of ISGylated proteins in complemented cWT ISG15 cell lysates, while this enhancement
was absent in complemented mutant cISG15-AA cell lysates (Fig. 5A).
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FIG 4 Function of macroautophagy in wild-type (WT) and ISG15 knockout (KO) cells. (A) WT and ISG15
KO A549 cells were cultured with or without IFN-␥ (100 U/ml) for 24 h. Cell lysates were prepared, and
equal amounts of protein were loaded for immunoblotting. The expression of autophagy proteins ATG5,
p62, and NDP52 was determined by immunoblotting with antigen-speciﬁc antibodies. A parallel blot was
probed for actin as the loading control. LI-COR IRDye 800CW (green) goat anti-rabbit (ATG5 and NDP52
blot) or goat anti-mouse (actin blot) IgG or LI-COR IRDye 680RD (red) goat anti-guinea pig (p62 blot) IgG
were used as secondary antibodies for detection. (B) LC3 levels were compared by immunoblotting cell
lysates from wild-type (WT) and ISG15 KO A549 cells grown in ⫾ IFN-␥ (100 U/ml) for 24 h using rabbit
polyclonal LC3 as the primary antibody and LI-COR IRDye 800CW (green) goat anti-rabbit IgG as the
secondary antibody. The same blot was reprobed for actin using mouse monoclonal actin antibody
followed by LI-COR IRDye 680RD (red) goat anti-mouse IgG as the loading control. (C) Induction of
autophagy was studied in wild-type (WT) and ISG15 KO A549 cells by comparing LC3 II levels of cells
grown for 24 h in the presence of different concentrations of rapamycin (Rap). LI-COR IRDye 800CW
(green) goat anti-rabbit IgG was used as the secondary antibody. A parallel blot was probed with mouse
monoclonal actin antibody followed by LI-COR IRDye 680RD (red) goat anti-mouse IgG. (D and E)
Autophagosome formation was studied in wild-type (WT) and ISG15 KO A549 cells with or without
baﬁlomycin A1 (Baf) and rapamycin (Rap). Representative images are shown on the right. Scale
bar ⫽ 5 m. Autophagosomes were stained with polyclonal rabbit LC3 antibody. Alexa Fluor 488 (green)
conjugated rabbit IgG antibody was used as the secondary antibody. Examples of puncta are indicated
with white arrows.

To examine the role of ISG15 in IFN-␥-dependent growth restriction, we stimulated
wild-type, ISG15 KO, complemented wild-type ISG15 (cWT ISG15), or complemented
mutant ISG15 (cISG15-AA) cells with IFN-␥ and measured T. gondii growth 36 h
postinfection. Growth of the parasite normally proceeds by binary ﬁssion with a half-life
of ⬃8 h such that at 36 h postinfection, the vacuoles contain clusters of parasites that
range from 1 parasite/vacuole to 8 parasites/vacuole. Previous studies have shown that
vacuoles that become ubiquitinated in IFN-␥-treated HeLa cells are restricted in growth
such that this distribution is skewed to smaller cluster sizes (i.e., replication is inhibited)
(22). The growth inhibition phenotype depends on ubiquitination and is not evident in
Ub-negative compartments (22). As such, we scored the number of parasite/ubiquitin
(Ub)-positive vacuoles at 36 h postinfection in IFN-␥-treated cells. Wild-type (WT) cells
restrict the growth of T. gondii in Ub-positive vacuoles, as shown by the larger number
of single-parasite vacuoles, and this phenotype was lost in the ISG15 KO, where vacuole
sizes returned to the broader distribution seen in wild-type parasites that were not
ubiquitinated (Fig. 5B and C). Complementation of ISG15 KO cells with the wild-type
ISG15 construct (i.e., cWT ISG15) rescued the growth restriction phenotype, while
September/October 2020 Volume 11 Issue 5 e00852-20
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FIG 5 ISG15 is required to restrict T. gondii growth in IFN-␥-activated A549 cells. (A) Immunoblot of
ISG15KO cells complemented with functional wild-type ISG15 (cWT ISG15) or ISGylation-defective ISG15
(cISG15-AA) construct. Cells were grown with or without IFN-␥ (100 U/ml) for 24 h. ISG15 and ISGylation
levels in cell lysates were determined by immunoblotting with rabbit polyclonal ISG15 antibody followed
by LI-COR IRDye 800CW (green) goat anti-rabbit IgG. Actin was probed as the loading control using
mouse monoclonal actin antibody and LI-COR IRDye 680RD (red) goat anti-mouse IgG. (B and, C)
Wild-type (WT), ISG15 KO, and complemented (cISG15 or cISG15-AA) A549 cells were cultured in IFN-␥
(100 U/ml) for 24 h and infected with type III T. gondii (CTG). Cells were washed 2 h postinfection, and
the numbers of parasites per vacuole were counted in ubiquitin-positive (Ub⫹) versus ubiquitin-negative
(Ub-) vacuoles at 36 h postinfection by immunofluorescence microscopy. The values represent means ⫾
standard error from three independent experiments. Two-way ANOVA was used to determine statistical
signiﬁcance. P values of ⱕ0.001 (***) were considered statistically signiﬁcant. ns, not signiﬁcant. Representative images are shown on the right. Scale bar ⫽ 5 m. Parasites (red) were stained with rabbit
anti-GRA7. Ubiquitin (green) was stained with mouse monoclonal ubiquitin antibody. Alexa Fluor 594
(red) conjugated rabbit and Alexa Fluor 488 (green) conjugated mouse IgG antibodies were used as
secondary antibodies for staining parasites and ubiquitin, respectively. Nuclei were stained with DAPI.
The white arrows indicate parasite-containing, Ub-positive (Ub⫹), and Ub-negative (Ub-) vacuoles.

complementation with the ISGylation-defective construct (i.e., cISG15-AA) failed to
rescue growth restriction (Fig. 5B). None of the lines showed signiﬁcant differences in
parasite growth in ubiquitin-negative vacuoles, consistent with previous ﬁndings in
HeLa cells. We conclude that ISG15 and ISGylation are important for IFN-␥-dependent
restriction of T. gondii by the noncanonical autophagy pathway in human cells.
ISG15 establishes cross talk between IFN-␥ and ATG pathways. ISG15 lies at the
center of the ATG5 interactome, and it is predicted to interact with a number of host
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TABLE 2 Overlap between ISG15 immunoprecipitation and BirA-ATG5 interactome

aFold

Gene name
ALDOA
LUZP1
TJP1
LMNA
LDHA
STAT1
SQSTM1
PGK1
DHX9
DHX15
RPL23A
WARS
TAP1

Fold changea
6.3
6
3.4
2.4
2.2
1.8
1.5
1.3
1.1
1.1
1
1
1

cISG15-AAb
2
1
2
5
5
7
10
3
23
4
11
8
5

cWT ISG15b
13
6
8
12
12
13
15
4
24
5
11
8
5

change in normalized weighted spectra in cWT ISG15 versus cISG15-AA.
represent normalized weighted spectra over 3 replicates.

bColumns

defense proteins that are present in the interactome. To establish the central role of
ISG15 in this network, we immunoprecipitated ISG15 from IFN-␥-treated A549 cells
complemented with wild-type ISG15 (i.e., cWT ISG15) and the ISGylation-defective
ISG15 form (i.e., cISG15-AA). Mass spectrometry results from three independent replicates were used to characterize interacting proteins (based on ⱖ3 peptides in a cWT
ISG15 sample and fold change in normalized weighted spectra of ⱖ1 in wild-type
versus mutant ISG15) that were either conjugation dependent or independent (Table S1). Comparing all ISG15 immunoprecipitated proteins to the ATG5 proximity
labeling interactome, we identiﬁed 13 shared proteins (Table 1 and 2, Fig. 6A). The
interaction of 10 of these shared proteins is partially conjugation dependent, as their
fold change in normalized weighted spectra was ⬎1 in wild-type (i.e., cWT ISG15)
relative to mutant ISG15 (i.e., cISG15-AA) samples (Table 2). The STRING network of the
13 shared proteins showed interactions similar to the ATG5 interactome and included
proteins involved in IFN-␥ responses (i.e., STAT1, WARS, and TAP1), glycolytic enzymes
(i.e., ALODOA, LDHA, and PGK1), and several RNA binding factors important in antiviral
defense (i.e., DHX9 and DHX15) (Fig. 1C and 6B). Interestingly, the adaptor protein p62
(SQSTM1), which showed defective recruitment to PV in the absence of ISG15 (Fig. 1B),
was 1.5-fold more abundant in wild-type ISG15 complemented cells (cWT ISG15)
compared to mutant ISG15 complemented cells (cISG15-AA), suggesting that its interaction is partially conjugation dependent (Table 2). The adaptor NDP52 was not
abundant in either sample, suggesting that its interaction with ISG15 is of lower afﬁnity,
although it was observed in one of the cWT ISG15 samples (two peptides in one of the
three replicates).
DISCUSSION
Control of T. gondii replication in human HeLa cells relies on a noncanonical ATG
pathway that is dependent on IFN-␥ (22). Ablation of core members of this pathway,
such as ATG16L1 or ATG7 compromises IFN-␥-mediated control of parasite replication
(22). Concordant with this dependence, recruitment of ATG adaptors and LC3B to
vacuoles containing susceptible parasites requires activation by IFN-␥ (22). However,
the basis for why IFN-␥ control of infection requires components of the ATG pathway
has not been deﬁned in previous studies. Here, we demonstrate that ISG15, which is
upregulated by IFN-␥ along with other members of the ISGylation pathway, interacts
with members of the ATG pathway. ATG mediators p62, NDP52, and LC3 showed
decreased recruitment to vacuoles containing a susceptible strain of the parasite in the
absence of ISG15, despite there being no global impact on the ATG pathway. ISG15 was
required for control of parasite replication in IFN-␥-treated cells as shown by loss of
control in ISG15 knockout cells. Moreover, ISGylation of cellular proteins was important
for ATG-mediated cell-autonomous immunity against T. gondii. Collectively, our data
September/October 2020 Volume 11 Issue 5 e00852-20
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Identiﬁed proteins
Fructose-bisphosphate aldolase A
Leucine zipper protein 1
Tight junction protein 1 (Zona occludens 1), isoform CRA_a
Prelamin-A/C
L-lactate dehydrogenase A chain
Signal transducer and activator of transcription 1-alpha/beta
Sequestosome-1
Phosphoglycerate kinase 1
ATP-dependent RNA helicase A
Pre-mRNA-splicing factor ATP-dependent RNA helicase
60S ribosomal protein L23a
Tryptophan-tRNA ligase, cytoplasmic
Antigen peptide transporter 1
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FIG 6 Interaction of ISG15 and ATG5 in restriction of T. gondii growth in human cells. (A) Venn diagram representing the overlap
between BirA-ATG5 proximity labeling and proteins immunoprecipitated with ISG15. Proteins identiﬁed by mass spectrometry from
ISG15 immunoprecipitation assay were analyzed using Scaffold version 4. 0. The normalized weighted spectra of IFN-␥-stimulated cWT
ISG15 samples were compared with conjugation-defective cISG15-AA samples. Proteins were included based on peptide count (ⱖ3 in
cWT ISG15) and fold change in normalized weighted spectra (ⱖ1) (Table 2). (B) The ISG15 interactome was built in the STRING database
version 10.5. Nodes (ﬁlled circles) represent proteins and edges indicate interactions as described in Fig. 1 (C) Proposed model for role
of ISG15 in connecting autophagy and IFN-␥-dependent restriction of T. gondii growth in human cells.
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establish a role of ISG15 in linking the ATG pathway with IFN-␥-dependent restriction
of T. gondii growth in human cells.
To deﬁne potential interactions between ATG and IFN-␥, we used proximitydependent biotin labeling to identify partners of ATG5 that were induced by IFN-␥
treatment. Network analysis of the ATG5 interactome identiﬁed ISG15 as a central hub
connecting ATG proteins with IFN-␥-induced genes, many of which are involved in
pathogen control (9, 25, 26). ISG15 was strongly induced in IFN-␥-stimulated samples
and showed greater association with ATG5 relative to control cells. Enhanced IFN-␥dependent ISGylation in human cell lines demonstrated that IFN-␥ treatment also
upregulates enzymes of the ISGylation pathway, as described previously for type I IFN
(51). ISG15 expression is normally induced in host cells by a variety of factors, including
viral infection, TLR ligands such as lipopolysaccharide and poly IC, tumor necrosis
factor-␣, or type I, II, and III IFNs (29, 48, 52). ISG15 is best known for its role in viral
infection (53), and in contrast, there are only a few studies describing its role in bacterial
and fungal infections (54–58). Our data indicate that ISG15 also plays an important role
in IFN-␥-dependent cell-autonomous immunity against the protozoan parasite T. gondii
in human cells. Type I IFN also contributes to cell-autonomous control of T. gondii
infection (59), suggesting that ISG15 may also play an important role in this context.
Separate studies have shown that in cells where ISGylation is enhanced, induction of
autophagy is associated with greater control of intracellular Listeria monocytogenes (60).
Together, these ﬁndings suggest that ISG15 plays a broader role in control of intracellular pathogens than previously recognized from its role in antiviral defenses.
Our ﬁndings demonstrate that ISG15 promotes IFN-␥-dependent recruitment of ATG
mediators p62, NDP52, and LC3 to PV. Each of these adaptors was decreased, although
not completely absent, in ISG15 KO cells, suggesting that ISG15 facilitates their recruitment to the PV. Interestingly, ubiquitination of the PV did not require ISG15, suggesting
that this modiﬁcation lies upstream of the recruitment of ATG adaptors. Kinetic studies
of the labeling of PVs containing susceptible strains of T. gondii in HeLa cells support
ubiquitination as the initial step in the process, followed by recruitment of p62 and
NDP52 and, ﬁnally, deposition of LC3 (22). The kinetics of recruitment observed here in
A549 cells are also consistent with this pathway of sequential recruitment. Vacuole
ubiquitination is also an early step in the process of xenophagy, a pathway responsible
for clearance of intracellular bacteria (23). Intracellular vacuoles containing pathogens
such as Salmonella and Mycobacterium often become damaged and reveal glycans on
the inner surface of the vacuole that are recognized by the cytosolic protein galectin 8,
which is recognized by NDP52 through a GALB1 domain (61). Subsequently, a variety
of ubiquitin ligases, including LRSAM1, PARKIN, and LUBAC, ubiquitinate intracellular
bacteria, leading to clearance by xenophagy (62). Studies of T. gondii PVs formed in
HUVEC cells stimulated with IFN-␥ also demonstrated slightly elevated levels of galectin
8 staining, and these compartments are also ubiquitinated and recruit ATG adaptors
such as NDP52 and p62 (24). Whether early membrane damage and galectin staining
also underlie susceptibility of T. gondii PVs to ubiquitination in HeLa cells remains
unknown. There are more than 600 putative ubiquitin ligases in human cells (63), and
the basis for selective ubiquitination of PV containing T. gondii is presently unknown.
However, type I strains are highly resistant to this pathway (22), suggesting the
presence of parasite factors that are able to counteract ATG-mediated control.
Previously, it was reported that bone marrow-derived macrophages from ISG15deﬁcient mice have reduced levels of ATG proteins on stimulation with type I IFN (64).
However, in our studies using the human lung epithelial cell line A549, we did not
observe decreased expression of ATG proteins in the absence of ISG15. Although
previous reports have indicated that T. gondii infection can counteract autophagy to
promote parasite survival (65), we did not observe appreciable differences in the core
components involved in restriction of parasite growth in response to IFN-␥ treatment.
Additionally, macroautophagy induced by a combination of rapamycin and baﬁlomycin
A1 was not affected in A549 cells in the absence of ISG15. Hence, ISG15 does not
appear to be required for macroautophagy, but rather, it speciﬁcally affects recruitment
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of ATG adaptors such as NDP52, p62, and LC3 to the PV. The mechanism by which
ISG15 facilitates recruitment of these adaptors is not known, but it may rely on
structural similarity between ubiquitin and ISG15. The adaptor p62 has a ubiquitin
binding domain (UBA) that preferentially recognizes K63-linked ubiquitin (37). Additionally, p62 may interact with ISG15 due to its structural resemblance to ubiquitin, a
feature that has previously been shown to facilitate recruitment of proteins to aggresomes for degradation (66). Similarly, the presence of a ubiquitin binding domain
(UBZ) in NDP52 (67) may facilitate interaction with ISG15 and recruitment to the PV. In
addition to the potential for these interactions, our data also argue that the
conjugation-dependent functions of ISG15 are primarily responsible for ATG-mediated
control of T. gondii growth. Consistent with this prediction, the adaptor p62 was also
detected as a conjugation-dependent interaction, suggesting that it can be covalently
modiﬁed by ISG15, which may further enhance recruitment. However, recruitment of
these adaptors to PV is not completely abrogated in the absence of ISG15, suggesting
that other mediators may also be involved.
In a previous study using HeLa cells, we demonstrated that recruitment of GFP-LC3B
was associated with restricted growth of the parasite in HeLa cells (22). Here, we used
an antibody to LC3, which reportedly recognizes LC3A, LC3B, and LC3C but not
GABARAP or GATE-16, to show recruitment to PVs in A549 cells. This antibody also
cross-reacts with mouse LC3 isoforms, and it has been used to monitor recruitment of
LC3 to PVs containing susceptible strains of T. gondii in mouse MEFS activated with
IFN-␥ (20). Although LC3B is commonly used as a marker for autophagosomes, human
cells express three isoforms of LC3 (i.e., LC3A, LC3B, and LC3C) and three related genes
(i.e., GABARAP, GABARAPL1, and GATE-16 [also known as GABARAPL2]), while mice
express ﬁve related proteins (LC3a, LC3b, Gabarap, Gabarapl1, and Gate-16) (68, 69).
Previous studies in the murine system demonstrated that Gate-16 is the primary
isoform associated with clearance of T. gondii in IFN-␥-activated MEF cells. These
ﬁndings suggest that evaluating other members of this family might be informative for
understanding the role of ATG in controlling growth of T. gondii in IFN-␥-activated
human cells.
ISG15 can exert its functional role as either free or conjugated forms (29, 70). In the
present study, we show that ISGylation is important for IFN-␥-dependent restriction of
parasite by ATG in human cells. The loss of IFN-␥-dependent parasite growth restriction
in ISG15 KO cells was complemented by reexpression of a wild-type copy of the protein,
but not by a conjugation-defective form that lacks key glycine residues required for
conjugation (50). Our result is in contrast to the studies in mice where unconjugated
ISG15 was found to contribute to formation of IL-1␤-producing dendritic cells during T.
gondii infection (30). ISG15 knockout mice showed a minor survival advantage at a low
dose of infection and no difference in parasite load, while at a higher dose, similar
survival was observed (30). The absence of a major phenotype for SG15 knockout mice
infected with T. gondii is likely due to the different pathways that are important for
cell-autonomous control in murine and human cells. In murine cells, recruitment of IRGs
and GBPs requires a noncanonical autophagy pathway (15); however, there is no known
role for ISG15 in this critical pathway. In contrast, human cells use a wider variety of
mechanisms (71), including a noncanonical pathway for vacuole engulfment and
growth restriction that exists in HeLa cells (22), and we show in the present studies in
A549 cells. Our ﬁndings indicate that the latter pathway is partially dependent on
ISG15, further distinguishing the mechanisms that operate in human cells. Our ﬁndings
provide a further example of species-speciﬁc differences in the functions of ISG15,
which have been extensively characterized previously in antiviral responses (72–74).
Our proteomic analysis demonstrates considerable overlap between proteins that
interact with ATG5, as deﬁned by proximity labeling, and proteins that immunoprecipitate with ISG15. A large percentage of the shared proteins are also induced by IFN-␥,
establishing the central role of ISG15 connecting the ATG pathway with IFN-␥dependent control of T. gondii in human cells. We show that ISG15 interacts with ⬎200
proteins in a conjugation-dependent and -independent manner following stimulation
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with IFN-␥. Our data are consistent with previous results showing that ISG15 interacts
with ⬎300 proteins in the presence of type I IFN (52). It is likely that IFN-␥-dependent
protein modiﬁcation by ISG15 can affect diverse cellular pathways and may have a
broader role besides governing cell-autonomous immunity to T. gondii.
In conclusion, our data identify the role of ISG15 in autophagy and IFN-␥-dependent
control of T. gondii infection in human cells as depicted in Fig. 6C. ISG15 recruits the
adaptors p62 and NDP52 to the PV, which in turn results in deposition of LC3, leading
to growth restriction of T. gondii by ATG. Interestingly, the interaction of p62 was
largely conjugation dependent, while NDP52 showed a weak conjugation-dependent
phenotype. In either case, the absence of ISG15 impaired adaptor recruitment to the PV
and resulted in failure of parasite restriction. We conclude that ISG15 connects the ATG
and IFN-␥-dependent control of T. gondii infection in human cells, suggesting that
ISG15 may also contribute to the control of other infections where IFN-␥-induced
autophagy plays an important role (75–77).
MATERIALS AND METHODS
Antibodies and reagents. Streptavidin magnetic beads were obtained from Thermo Fischer Scientiﬁc. Streptavidin conjugated to IRDye 800CW (LI-COR Biosciences) was used for detection of biotinylated
proteins on blots. ISG15 was detected using rabbit polyclonal ISG15 antibody (15981-1-AP; Proteintech).
Actin was detected using mouse anti-actin clone C4 (MAB1501; Millipore). Ubiquitin was detected using
mouse antibody clone FK2 (04-263; EMD Millipore Corporation). p62 was detected using guinea pig
polyclonal p62 antibody (GP62-C; Progen). NDP52 was detected with rabbit polyclonal antibody (122291-AP; Proteintech). LC3 (immunofluorescence assay) was detected with rabbit polyclonal antibody
(PM036; MBL International Corporation). Rabbit polyclonal LC3 (NB100-2220) and monoclonal rabbit
ATG5 (12994S), antibodies for immunoblotting, were obtained from Novus Biologicals and Cell Signaling
Technology, respectively. Antibodies used for detecting T. gondii parasites (mouse monoclonal DG52
against SAG1 and rabbit polyclonal anti-whole tachyzoite lysate) or the parasitophorous vacuole (rabbit
polyclonal GRA7) have been previously described (22). Goat anti-mouse, goat anti-rabbit, and goat
anti-guinea pig secondary antibodies conjugated to Alexa Fluor 488, Alexa Fluor 594, or Alexa Fluor 647
(Life Technologies) were used for immunofluorescence. Goat anti-mouse, anti-guinea pig, or anti-rabbit
IgG labeled with IRDye 800CW or 680RD (LI-COR Biosciences) were used as secondary antibodies for
immunoblotting.
Parasite culture. Tachyzoites of the type III CTG strain (ATCC 50842) were cultured in human foreskin
ﬁbroblast cells grown in Dulbecco’s modiﬁed Eagle’s medium (Invitrogen) supplemented with 3% fetal
bovine serum (FBS) (GE Healthcare Life Sciences), 10 mM glutamine (Thermo Fisher Scientiﬁc), 10 mM
HEPES (Sigma-Aldrich), pH 7.5, and 10 g/ml gentamicin (Thermo Fisher Scientiﬁc) at 37°C in 5% CO2.
Naturally egressed parasites were harvested as described previously (22). Parasite cultures and host cell
lines were conﬁrmed as negative for mycoplasma using a e-Myco plus kit (Intron Biotechnology).
Cell culture. HeLa cells stably expressing promiscuous biotin ligase BirA-ATG5 as a fusion protein
were generated by lentiviral transduction. BirA was cloned in-frame with ATG5 into the NotI restriction
site in pCDH-MCS-T2A-Puro (CD522A-1; System Biosciences) using the In-Fusion HD cloning kit (TaKaRa)
and conﬁrmed by Sanger sequencing. Lentivirus was produced in HEK293T cells by cotransfecting
BirA-ATG5 expression plasmid, envelope plasmid pCMV-VSVG (8454; Addgene), and packaging plasmid
psPAX2 (12260; Addgene). HeLa cells were transduced with the lentivirus and maintained in medium
supplemented with 1 g/ml puromycin (Thermo Fisher Scientiﬁc). ATG16L1 knockout cells have been
previously described (22). HeLa cells were grown in minimum essential medium (Sigma-Aldrich) supplemented with 10% deﬁned fetal bovine serum (FBS; GE Healthcare Life Sciences), 4 mM L-glutamine
(Thermo Fisher Scientiﬁc), and 10 mM HEPES (Sigma-Aldrich), pH 7.5, at 37°C in 5% CO2.
Wild-type and ISG15 knockout (ISG15KO) A549 cells were produced with a CRISPR/Cas9 approach. Target sequences for CRISPR interference were selected using the CRISPR guide design tools
available at the Zhang laboratory (https://zlab.bio/guide-design-resources). Two seed sequences
preceding the protospacer-adjacent motif (PAM) used are as follows: g5, CGACGAACCTCTGAGCATCC; g6,
GCACGCCTTCCAGCAGCGTC. The sense and antisense oligonucleotides were designed to incorporate the
restriction enzyme site BbsI of pX459 (62988; Addgene) bicistronic expression vector expressing Cas9 and
synthetic single-guide RNA (78). The oligonucleotide DNAs were annealed, phosphorylated, and incorporated into pX459 vector linearized with BbsI restriction enzyme. A549 cells were transfected with
ISG15-targeting pX459 plasmid with Lipofectamine 2000 (Thermo Fisher Scientiﬁc) according to the
manufacturer’s instructions. The cells were selected with puromycin (2 g/ml for 48 h) and replated to
a 96-well plate at a density of 0.5 cells per well. The individual colonies were picked, and ISG15 expression
was checked by immunoblotting. The deletion of ISG15 loci in the genome was further conﬁrmed by
targeted sequencing (Genome Engineering Center, Washington University). The percentage of respective
indels and the sequencing results are shown in the supplemental material (Fig. S3A and B). Wild-type and
ISG15 KO A549 cells were grown in Dulbecco’s modiﬁed Eagle’s medium supplemented with 10% FBS,
10 mM glutamine, 10 mM HEPES, pH 7.5, and 10 g/ml gentamicin (Thermo Fisher Scientiﬁc) at 37°C in
5% CO2.
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Complementation of A549 cells. ISG15 KO A549 cells were transduced with lentivirus to express
complemented copies of wild-type ISG15 (cWT ISG15) and ISGylation-defective ISG15 (cISG15-AA). To
generate a conjugation-defective form of ISG15, the glycines that function in conjugation of the
wild-type sequence LRLRGG were replaced by alanine to generate a construct expressing LRLRAA (50).
The ISGylation-defective ISG15 (cISG15-AA) was constructed by changing the nucleotides corresponding
to glycine (GGT GGG) residues to those encoding alanine (GCG GCG) in the reverse primer. HA-tagged
full-length wild-type ISG15 and its ISGylation-defective form were cloned in lentivirus vector pCDH-UbCMCS-EF1␣-Hygro (CD615B-1; System Biosciences) at the NheI and NotI sites using the In-Fusion HD
cloning kit (TaKaRa). Lentivirus was produced by cotransfecting lentiviral expression vector, pCMV-VSVG
(8454; Addgene), and psPAX2 (12260; Addgene) in HEK293T cells. Virus-containing cell supernatants
were collected 48 h posttransfection, ﬁltered through a 0.45-m ﬁlter, and used to transduce A549 ISG15
KO cells. Cells were grown in the presence of 1 mg/ml hygromycin B (GoldBio) 48 h postransduction to
select for stably integrated cells.
Sample preparation for mass spectrometry and data analysis. Permissive biotin labeling. HeLa
cells expressing BirA-ATG5 were cultured with or without 100 U/ml IFN-␥ (R&D Systems) for 24 h and
grown in the presence or absence of biotin (Sigma-Aldrich) for 18 h. Proteins were extracted in
radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris, pH 7.5), 150 mM sodium chloride, 0.1%
sodium dodecyl sulfate, 0.5% sodium deoxycholate, and 1% Triton X-100) containing EDTA-free protease
inhibitor cocktail (Roche). The extracted proteins were afﬁnity puriﬁed by incubation with streptavidin
magnetic beads (Thermo Fisher Scientiﬁc). At the end of the incubation period, beads were washed as
described previously (79) and given a ﬁnal wash with PBS.
Immunoprecipitation. For immunoprecipitation, lysates were prepared from A549 cells and were
incubated with rabbit polyclonal ISG15 antibody (Proteintech) for 16 h at 4°C. The immunocomplex was
pulled down with Dynabeads protein G (Thermo Fisher Scientiﬁc). The beads were separated and washed
thrice with PBS-Tween (0.02%) and thrice with PBS.
Mass spectrometry (MS) analysis. The beads were submitted for analysis to the Proteomics and
Metabolomics Facility, Center for Biotechnology, University of Nebraska Lincoln. The magnetic bead
samples were resuspended in ammonium bicarbonate and reduced with 5 mM DTT at 37°C for 1 h. The
proteins were alkylated (10 mM iodoacetamide for 20 min at 22°C in the dark), followed by quenching
with DTT (1 M). Trypsin digestion was done overnight at 37°C with shaking. The supernatant was dried
and redissolved in 2.5% acetonitrile and 0.1% formic acid. Samples were run by nanoscale liquid
chromatography (nanoLC)-MS/MS using a 2-h gradient on a 0.075-mm by 250-mm Waters CSH C18
column feeding into a Q-Exactive high-frequency (HF) mass spectrometer. Data were analyzed using
Mascot version 2.6.2 (Matrix Science, London, UK). Mascot was set up to search the cRAP_20150130.fasta
(123 entries), Custom5_20190917.fasta (1 entry), and UniProt-human_20190219 database (73,928 entries)
assuming the digestion enzyme trypsin. Mascot was searched with a fragment ion mass tolerance of
0.060 Da and a parent ion tolerance of 10.0 ppm. Deamidation of asparagine and glutamine, oxidation
of methionine, and carbamidomethylation of cysteine were speciﬁed in Mascot as variable modiﬁcations.
Network analysis. For both sets of samples, identiﬁed proteins were analyzed using Scaffold version
4.0 (number of peptides, 2; protein threshold, 99%; peptide threshold, 95%) (80). The interaction among
the shortlisted proteins was generated online using the STRING database at https://version-10-5.string
-db.org/cgi/input.pl (81) using a minimum interaction score of 0.4.
Western blotting. Beads or cell lysates were boiled in SDS sample buffer, resolved on polyacrylamide
gel, transferred to the nitrocellulose membrane, and probed with IRDye conjugated streptavidin or
primary antibodies against cellular proteins followed by incubation with IRDye conjugated secondary
antibodies.
Immunofluorescence microscopy. Samples were viewed under a Zeiss Axioskop 2 MOT Plus
microscope (Carl Zeiss) using a ⫻63 Plan-Apochromat lens, numerical aperture 1.40, and images were
acquired with an AxioCam MRm camera (Carl Zeiss) with AxioVision version 4.6. Images were processed
in Fiji-ImageJ and Photoshop CS6 version 13.0x64.
Recruitment of adaptors and parasite vacuolar growth. A549 cells were stimulated with IFN-␥
(100 U/ml) for 24 h, infected with tachyzoites of the type III T. gondii strain CTG, and washed 2 h
postinfection to remove extracellular parasites. The cells were ﬁxed in 4% formaldehyde 6 h postinfection
to study the recruitment of autophagy mediators to the parasite by using antigen-speciﬁc antibodies.
Control cells were grown in the absence of IFN-␥. T. gondii was localized using antibodies against the
tachyzoites or parasite surface antigen 1 (SAG1) or parasite dense granule protein (GRA7) present on the
PV. Alternatively, for examining the colocalization of ubiquitin and adaptors on the PV, we infected cells
with a green fluorescent protein (GFP)-expressing strain of CTG. Recruitment of ubiquitin, p62, NDP52,
and LC3 were quantiﬁed from 30 or more PV on each of three separate coverslips per group. Vacuolar
growth of T. gondii was studied 36 h postinfection by enumerating the number of parasites per vacuole
from 30 PV on 3 individual coverslips.
Autophagosome formation. A549 cells were grown with or without rapamycin 5 M (SigmaAldrich) for 24 h and then treated with baﬁlomycin A1 (100 nm) (InvivoGen) for 4 h before ﬁxation in 4%
formaldehyde. Autophagosome was detected using rabbit anti-LC3 staining to enumerate LC3 puncta
from 30 or more cells on each of 3 separate coverslips per group. LC3 puncta per cell were quantiﬁed
using Volocity version 6.3 software.
Statistical analysis. Statistical analyses were done using GraphPad Prism 7. Unless otherwise
speciﬁed, data from three independent experiments, each with three internal replicates, were combined
and plotted as means ⫾ standard error of means. Two-way analysis of variance (ANOVA) was used to
determine statistical signiﬁcance between samples, where the ﬁrst variable was the groups and the
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second variable was separate experiments. P values of ⱕ0.05 (*), ⱕ0.01 (**), ⱕ0.001 (***), and ⱕ0.0001
(****) were considered statistically signiﬁcant.

ACKNOWLEDGMENTS
We are grateful to Jennifer Barks for assistance with cell culture, Michael Naldrett
and Sophie Alvarez, Nebraska Center for Biotechnology, for assistance with mass
spectrometry, Wandy Beatty, Microbiology Imaging Facility, Washington University
School of Medicine, for assistance with microscopy, and members of the Sibley laboratory for helpful comments.
This work was supported in part by grants from the NIH (AI118426 to L.D.S., U19
AI142784 to H.W.V., AI080672 to D.J.L., and 5T32 CA009547 to Y.-C.P.). We also acknowledge support from the Washington University Rheumatic Diseases Research Resourcebased Center (P30 AR073752) for genome engineering and sequencing.
H.W.V. is a founder of Casma Therapeutics. None of the studies here were funded by
Casma Therapeutics. We have no other conﬂicts to disclose.

REFERENCES
1. Dunay IR, Gajurel K, Dhakal R, Liesenfeld O, Montoya JG. 2018. Treatment
of toxoplasmosis: historical perspective, animal models, and current
clinical practice. Clin Microbiol Rev 31:e00057-17.
2. Sibley LD. 2011. Invasion and intracellular survival by protozoan parasites. Immunol Rev 240:72–91. https://doi.org/10.1111/j.1600-065X.2010
.00990.x.
3. Howe DK, Sibley LD. 1995. Toxoplasma gondii comprises three clonal
lineages: correlation of parasite genotype with human disease. J Infect
Dis 172:1561–1566. https://doi.org/10.1093/infdis/172.6.1561.
4. Suzuki Y, Orellana MA, Schreiber RD, Remington JS. 1988. Interferongamma: the major mediator of resistance against Toxoplasma gondii.
Science 240:516 –518. https://doi.org/10.1126/science.3128869.
5. Yap GS, Sher A. 1999. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular
pathogen, Toxoplasma gondii. J Exp Med 189:1083–1092. https://doi
.org/10.1084/jem.189.7.1083.
6. Nathan CF, Murray HW, Wiebe ME, Rubin BY. 1983. Identiﬁcation of
interferon gamma as the lymphokine that activates human macrophage
oxidative metabolism and antimicrobial activity. J Exp Med 158:
670 – 689. https://doi.org/10.1084/jem.158.3.670.
7. Pfefferkorn ER. 1984. Interferon-gamma blocks the growth of Toxoplasma gondii in human ﬁbroblasts by inducing the host to degrade
tryptophan. Proc Natl Acad Sci U S A 81:908 –912. https://doi.org/10
.1073/pnas.81.3.908.
8. Kim BH, Shenoy AR, Kumar P, Bradﬁeld CJ, MacMicking JD. 2012. IFNinducible GTPases in host cell defense. Cell Host Microbe 12:432– 444.
https://doi.org/10.1016/j.chom.2012.09.007.
9. MacMicking JD. 2012. Interferon-inducible effector mechanisms in cellautonomous immunity. Nat Rev Immunol 12:367–382. https://doi.org/
10.1038/nri3210.
10. Khaminets A, Hunn JP, Konen-Waisman S, Zhao YO, Preukschat D, Coers
J, Boyle JP, Ong YC, Boothroyd JC, Reichmann G, Howard JC. 2010.
Coordinated loading of IRG resistance GTPases on to the Toxoplasma
gondii parasitophorous vacuole. Cell Microbiol 12:939 –961. https://doi
.org/10.1111/j.1462-5822.2010.01443.x.
11. Zhao Y, Ferguson DJ, Wilson DC, Howard JC, Sibley LD, Yap GS. 2009.
Virulent Toxoplasma gondii evade immunity-related GTPas-mediated
parasite vacuole disruption within primed macrophages. J Immunol
182:3775–3781. https://doi.org/10.4049/jimmunol.0804190.
12. Degrandi D, Kravets E, Konermann C, Beuter-Gunia C, Klumpers V,
Lahme S, Wischmann E, Mausberg AK, Beer-Hammer S, Pfeffer K. 2013.
September/October 2020 Volume 11 Issue 5 e00852-20

13.

14.

15.

16.

17.

18.

19.
20.

21.

22.

Murine guanylate binding protein 2 (mGBP2) controls Toxoplasma gondii
replication. Proc Natl Acad Sci U S A 110:294 –299. https://doi.org/10
.1073/pnas.1205635110.
Selleck EM, Fentress SJ, Beatty WL, Degrandi D, Pfeffer K, Virgin HW IV,
Macmicking JD, Sibley LD. 2013. Guanylate-binding protein 1 (Gbp1)
contributes to cell-autonomous immunity against Toxoplasma gondii.
PLoS Pathog 9:e1003320. https://doi.org/10.1371/journal.ppat.1003320.
Yamamoto M, Okuyama M, Ma JS, Kimura T, Kamiyama N, Saiga H, Ohshima
J, Sasai M, Kayama H, Okamoto T, Huang DC, Soldati-Favre D, Horie K,
Takeda J, Takeda K. 2012. A cluster of interferon-gamma-inducible p65
GTPases plays a critical role in host defense against Toxoplasma gondii.
Immunity 37:302–313. https://doi.org/10.1016/j.immuni.2012.06.009.
Hunter CA, Sibley LD. 2012. Modulation of innate immunity by Toxoplasma gondii virulence effectors. Nat Rev Microbiol 10:766 –778. https://
doi.org/10.1038/nrmicro2858.
Hakimi MA, Olias P, Sibley LD. 2017. Toxoplasma effectors targeting host
signaling and transcription. Clin Microbiol Rev 30:615– 645. https://doi
.org/10.1128/CMR.00005-17.
Howard JC, Hunn JP, Steinfeldt T. 2011. The IRG protein-based resistance
mechanism in mice and its relation to virulence in Toxoplasma gondii. Curr
Opin Microbiol 14:414–421. https://doi.org/10.1016/j.mib.2011.07.002.
Clough B, Frickel EM. 2017. The toxoplasma parasitophorous vacuole: an
evolving host-parasite frontier. Trends Parasitol 33:473– 488. https://doi
.org/10.1016/j.pt.2017.02.007.
Levine B, Mizushima N, Virgin HW. 2011. Autophagy in immunity and
inﬂammation. Nature 469:323–335. https://doi.org/10.1038/nature09782.
Choi J, Park S, Biering SB, Selleck E, Liu CY, Zhang X, Fujita N, Saitoh T,
Akira S, Yoshimori T, Sibley LD, Hwang S, Virgin HW. 2014. The parasitophorous vacuole membrane of Toxoplasma gondii is targeted for
disruption by ubiquitin-like conjugation systems of autophagy. Immunity 40:924 –935. https://doi.org/10.1016/j.immuni.2014.05.006.
Zhao Z, Fux B, Goodwin M, Dunay IR, Strong D, Miller BC, Cadwell K,
Delgado MA, Ponpuak M, Green KG, Schmidt RE, Mizushima N, Deretic V,
Sibley LD, Virgin HW. 2008. Autophagosome-independent essential
function for the autophagy protein Atg5 in cellular immunity to intracellular pathogens. Cell Host Microbe 4:458 – 469. https://doi.org/10
.1016/j.chom.2008.10.003.
Selleck EM, Orchard RC, Lassen KG, Beatty WL, Xavier RJ, Levine B, Virgin
HW, Sibley LD. 2015. A noncanonical autophagy pathway restricts Toxoplasma gondii growth in a strain-speciﬁc manner in IFN-gammaactivated human cells. mBio 6:e01157-15. https://doi.org/10.1128/mBio
.01157-15.
mbio.asm.org 17

Downloaded from http://mbio.asm.org/ on November 5, 2020 at Washington University in St. Louis

SUPPLEMENTAL MATERIAL
Supplemental material is available online only.
FIG S1, TIF ﬁle, 1 MB.
FIG S2, TIF ﬁle, 0.2 MB.
FIG S3, TIF ﬁle, 2.2 MB.
TABLE S1, XLS ﬁle, 0.04 MB.

®

Bhushan et al.

September/October 2020 Volume 11 Issue 5 e00852-20

44.

45.

46.

47.

48.
49.

50.

51.

52.

53.

54.

55.

56.

57.

58.

59.

down-regulation of miR-181a and miR-30a. J Biol Chem 292:264 –277.
https://doi.org/10.1074/jbc.M116.752584.
Ehrchen JM, Sunderkotter C, Foell D, Vogl T, Roth J. 2009. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate
ampliﬁer of infection, autoimmunity, and cancer. J Leukoc Biol 86:
557–566. https://doi.org/10.1189/jlb.1008647.
Wang F, Zhang S, Jeon R, Vuckovic I, Jiang X, Lerman A, Folmes CD,
Dzeja PD, Herrmann J. 2018. Interferon gamma induces reversible
metabolic reprogramming of M1 macrophages to sustain cell viability
and pro-inﬂammatory activity. EBioMedicine 30:303–316. https://doi
.org/10.1016/j.ebiom.2018.02.009.
Chow KT, Gale M, Jr, Loo YM. 2018. RIG-I and other RNA sensors in
antiviral immunity. Annu Rev Immunol 36:667– 694. https://doi.org/10
.1146/annurev-immunol-042617-053309.
Lesage S, Drouet V, Majounie E, Deramecourt V, Jacoupy M, Nicolas A,
Cormier-Dequaire F, Hassoun SM, Pujol C, Ciura S, Erpapazoglou Z,
Usenko T, Maurage CA, Sahbatou M, Liebau S, Ding J, Bilgic B, Emre M,
Erginel-Unaltuna N, Guven G, Tison F, Tranchant C, Vidailhet M, Corvol
JC, Krack P, Leutenegger AL, Nalls MA, Hernandez DG, Heutink P, Gibbs
JR, Hardy J, Wood NW, Gasser T, Durr A, Deleuze JF, Tazir M, Destee A,
Lohmann E, Kabashi E, Singleton A, Corti O, Brice A, French Parkinson’s
Disease Genetics Study, International Parkinson’s Disease Genomics
Consortium. 2016. Loss of VPS13C function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases PINK1/
Parkin-dependent mitophagy. Am J Hum Genet 98:500 –513. https://doi
.org/10.1016/j.ajhg.2016.01.014.
Perng YC, Lenschow DJ. 2018. ISG15 in antiviral immunity and beyond. Nat
Rev Microbiol 16:423–439. https://doi.org/10.1038/s41579-018-0020-5.
Mizushima N, Yoshimori T, Levine B. 2010. Methods in mammalian autophagy research. Cell 140:313–326. https://doi.org/10.1016/j.cell.2010.01
.028.
Lenschow DJ, Giannakopoulos NV, Gunn LJ, Johnston C, O’Guin AK,
Schmidt RE, Levine B, Virgin HW IV. 2005. Identiﬁcation of interferonstimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J Virol 79:13974 –13983. https://doi.org/10.1128/JVI.79.22
.13974-13983.2005.
Zhang D, Zhang DE. 2011. Interferon-stimulated gene 15 and the protein
ISGylation system. J Interferon Cytokine Res 31:119 –130. https://doi.org/
10.1089/jir.2010.0110.
Durfee LA, Lyon N, Seo K, Huibregtse JM. 2010. The ISG15 conjugation
system broadly targets newly synthesized proteins: implications for the
antiviral function of ISG15. Mol Cell 38:722–732. https://doi.org/10.1016/
j.molcel.2010.05.002.
Zhao C, Collins MN, Hsiang TY, Krug RM. 2013. Interferon-induced ISG15
pathway: an ongoing virus-host battle. Trends Microbiol 21:181–186.
https://doi.org/10.1016/j.tim.2013.01.005.
Dauphinee SM, Richer E, Eva MM, McIntosh F, Paquet M, Dangoor D,
Burkart C, Zhang DE, Gruenheid S, Gros P, Behr M, Malo D. 2014.
Contribution of increased ISG15, ISGylation and deregulated type I IFN
signaling in Usp18 mutant mice during the course of bacterial infections.
Genes Immun 15:282–292. https://doi.org/10.1038/gene.2014.17.
Bogunovic D, Byun M, Durfee LA, Abhyankar A, Sanal O, Mansouri D,
Salem S, Radovanovic I, Grant AV, Adimi P, Mansouri N, Okada S, Bryant
VL, Kong XF, Kreins A, Velez MM, Boisson B, Khalilzadeh S, Ozcelik U,
Darazam IA, Schoggins JW, Rice CM, Al-Muhsen S, Behr M, Vogt G, Puel
A, Bustamante J, Gros P, Huibregtse JM, Abel L, Boisson-Dupuis S,
Casanova JL. 2012. Mycobacterial disease and impaired IFN-gamma
immunity in humans with inherited ISG15 deﬁciency. Science 337:
1684 –1688. https://doi.org/10.1126/science.1224026.
Kimmey JM, Campbell JA, Weiss LA, Monte KJ, Lenschow DJ, Stallings CL.
2017. The impact of ISGylation during Mycobacterium tuberculosis infection in mice. Microbes Infect 19:249 –258. https://doi.org/10.1016/j
.micinf.2016.12.006.
Radoshevich L, Impens F, Ribet D, Quereda JJ, Nam Tham T, Nahori MA,
Bierne H, Dussurget O, Pizarro-Cerda J, Knobeloch KP, Cossart P. 2015. ISG15
counteracts Listeria monocytogenes infection. Elife 4:e06848. https://doi
.org/10.7554/eLife.06848.
Dong C, Gao N, Ross BX, Yu FX. 2017. ISG15 in host defense against Candida
albicans infection in a mouse model of fungal keratitis. Invest Ophthalmol
Vis Sci 58:2948–2958. https://doi.org/10.1167/iovs.17-21476.
Matta SK, Olias P, Huang Z, Wang Q, Park E, Yokoyama WM, Sibley LD.
2019. Toxoplasma gondii effector TgIST blocks type I interferon signaling
to promote infection. Proc Natl Acad Sci U S A 116:17480 –17491.
https://doi.org/10.1073/pnas.1904637116.
mbio.asm.org 18

Downloaded from http://mbio.asm.org/ on November 5, 2020 at Washington University in St. Louis

23. Huang J, Brumell JH. 2014. Bacteria-autophagy interplay: a battle for survival. Nat Rev Microbiol 12:101–114. https://doi.org/10.1038/nrmicro3160.
24. Clough B, Wright JD, Pereira PM, Hirst EM, Johnston AC, Henriques R,
Frickel EM. 2016. K63-linked ubiquitination targets Toxoplasma gondii for
endo-lysosomal destruction in IFNgamma-stimulated human cells. PLoS
Pathog 12:e1006027. https://doi.org/10.1371/journal.ppat.1006027.
25. Ivashkiv LB. 2018. IFNgamma: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy. Nat Rev Immunol
18:545–558. https://doi.org/10.1038/s41577-018-0029-z.
26. Schneider WM, Chevillotte MD, Rice CM. 2014. Interferon-stimulated
genes: a complex web of host defenses. Annu Rev Immunol 32:513–545.
https://doi.org/10.1146/annurev-immunol-032713-120231.
27. Korant BD, Blomstrom DC, Jonak GJ, Knight E, Jr. 1984. Interferoninduced proteins. Puriﬁcation and characterization of a 15,000-dalton
protein from human and bovine cells induced by interferon. J Biol Chem
259:14835–14839.
28. Villarroya-Beltri C, Guerra S, Sanchez-Madrid F. 2017. ISGylation: a key to
lock the cell gates for preventing the spread of threats. J Cell Sci
130:2961–2969. https://doi.org/10.1242/jcs.205468.
29. Dzimianski JV, Scholte FEM, Bergeron E, Pegan SD. 2019. ISG15: it’s
complicated. J Mol Biol 431:4203– 4216. https://doi.org/10.1016/j.jmb
.2019.03.013.
30. Napolitano A, van der Veen AG, Bunyan M, Borg A, Frith D, Howell S,
Kjaer S, Beling A, Snijders AP, Knobeloch KP, Frickel EM. 2018. Cysteinereactive free ISG15 generates IL-1beta-producing CD8alpha(⫹) dendritic
cells at the site of infection. J Immunol 201:604 – 614. https://doi.org/10
.4049/jimmunol.1701322.
31. Roux KJ, Kim DI, Raida M, Burke B. 2012. A promiscuous biotin ligase fusion
protein identiﬁes proximal and interacting proteins in mammalian cells. J
Cell Biol 196:801–810. https://doi.org/10.1083/jcb.201112098.
32. Roux KJ, Kim DI, Burke B, May DG. 2018. BioID: a screen for proteinprotein interactions. Curr Protoc Protein Sci 91:19.23.1–19.23.15.
33. Behrends C, Sowa ME, Gygi SP, Harper JW. 2010. Network organization
of the human autophagy system. Nature 466:68 –76. https://doi.org/10
.1038/nature09204.
34. von Mering C, Jensen LJ, Snel B, Hooper SD, Krupp M, Foglierini M, Jouffre
N, Huynen MA, Bork P. 2005. STRING: known and predicted protein-protein
associations, integrated and transferred across organisms. Nucleic Acids Res
33:D433–D437. https://doi.org/10.1093/nar/gki005.
35. Shibutani ST, Saitoh T, Nowag H, Munz C, Yoshimori T. 2015. Autophagy
and autophagy-related proteins in the immune system. Nat Immunol
16:1014 –1024. https://doi.org/10.1038/ni.3273.
36. Tsuboyama K, Koyama-Honda I, Sakamaki Y, Koike M, Morishita H,
Mizushima N. 2016. The ATG conjugation systems are important for
degradation of the inner autophagosomal membrane. Science 354:
1036 –1041. https://doi.org/10.1126/science.aaf6136.
37. Seibenhener ML, Babu JR, Geetha T, Wong HC, Krishna NR, Wooten MW.
2004. Sequestosome 1/p62 is a polyubiquitin chain binding protein
involved in ubiquitin proteasome degradation. Mol Cell Biol 24:
8055– 8068. https://doi.org/10.1128/MCB.24.18.8055-8068.2004.
38. Qin A, Lai DH, Liu Q, Huang W, Wu YP, Chen X, Yan S, Xia H, Hide G, Lun
ZR, Ayala FJ, Xiang AP. 2017. Guanylate-binding protein 1 (GBP1) contributes to the immunity of human mesenchymal stromal cells against
Toxoplasma gondii. Proc Natl Acad Sci U S A 114:1365–1370. https://doi
.org/10.1073/pnas.1619665114.
39. Lo UG, Pong RC, Yang D, Gandee L, Hernandez E, Dang A, Lin CJ, Santoyo
J, Ma S, Sonavane R, Huang J, Tseng SF, Moro L, Arbini AA, Kapur P, Raj
GV, He D, Lai CH, Lin H, Hsieh JT. 2019. IFNgamma-induced IFIT5
promotes epithelial-to-mesenchymal transition in prostate cancer via
miRNA processing. Cancer Res 79:1098 –1112. https://doi.org/10.1158/
0008-5472.CAN-18-2207.
40. Morrow AN, Schmeisser H, Tsuno T, Zoon KC. 2011. A novel role for
IFN-stimulated gene factor 3II in IFN-gamma signaling and induction of
antiviral activity in human cells. J Immunol 186:1685–1693. https://doi
.org/10.4049/jimmunol.1001359.
41. Jin M. 2019. Unique roles of tryptophanyl-tRNA synthetase in immune
control and its therapeutic implications. Exp Mol Med 51:1–10. https://
doi.org/10.1038/s12276-018-0196-9.
42. Zhang B, Liu X, Chen W, Chen L. 2013. IFIT5 potentiates anti-viral response
through enhancing innate immune signaling pathways. Acta Biochim Biophys Sin (Shanghai) 45:867–874. https://doi.org/10.1093/abbs/gmt088.
43. Riess M, Fuchs NV, Idica A, Hamdorf M, Flory E, Pedersen IM, Konig R.
2017. Interferons induce expression of SAMHD1 in monocytes through

®

ISG15 and Parasite Growth Restriction in Human Cells

September/October 2020 Volume 11 Issue 5 e00852-20

70. Bogunovic D, Boisson-Dupuis S, Casanova JL. 2013. ISG15: leading a
double life as a secreted molecule. Exp Mol Med 45:e18. https://doi.org/
10.1038/emm.2013.36.
71. Fisch D, Clough B, Frickel EM. 2019. Human immunity to Toxoplasma
gondii. PLoS Pathog 15:e1008097. https://doi.org/10.1371/journal.ppat
.1008097.
72. Gazzinelli RT, Mendonca-Neto R, Lilue J, Howard J, Sher A. 2014. Innate
resistance against Toxoplasma gondii: an evolutionary tale of mice, cats,
and men. Cell Host Microbe 15:132–138. https://doi.org/10.1016/j.chom
.2014.01.004.
73. Jeon YJ, Yoo HM, Chung CH. 2010. ISG15 and immune diseases. Biochim
Biophys Acta 1802:485– 496. https://doi.org/10.1016/j.bbadis.2010.02
.006.
74. Speer SD, Li Z, Buta S, Payelle-Brogard B, Qian L, Vigant F, Rubino E,
Gardner TJ, Wedeking T, Hermann M, Duehr J, Sanal O, Tezcan I, Mansouri N, Tabarsi P, Mansouri D, Francois-Newton V, Daussy CF, Rodriguez
MR, Lenschow DJ, Freiberg AN, Tortorella D, Piehler J, Lee B, GarciaSastre A, Pellegrini S, Bogunovic D. 2016. ISG15 deﬁciency and increased
viral resistance in humans but not mice. Nat Commun 7:11496. https://
doi.org/10.1038/ncomms11496.
75. Assani K, Tazi MF, Amer AO, Kopp BT. 2014. IFN-gamma stimulates
autophagy-mediated clearance of Burkholderia cenocepacia in human
cystic ﬁbrosis macrophages. PLoS One 9:e96681. https://doi.org/10
.1371/journal.pone.0096681.
76. Al-Zeer MA, Al-Younes HM, Braun PR, Zerrahn J, Meyer TF. 2009. IFNgamma-inducible Irga6 mediates host resistance against Chlamydia trachomatis via autophagy. PLoS One 4:e4588. https://doi.org/10.1371/
journal.pone.0004588.
77. Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V.
2004. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119:753–766.
https://doi.org/10.1016/j.cell.2004.11.038.
78. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. 2013. Genome
engineering using the CRISPR-Cas9 system. Nat Protoc 8:2281–2308.
https://doi.org/10.1038/nprot.2013.143.
79. Long S, Anthony B, Drewry LL, Sibley LD. 2017. A conserved ankyrin
repeat-containing protein regulates conoid stability, motility and cell
invasion in Toxoplasma gondii. Nat Commun 8:2236. https://doi.org/10
.1038/s41467-017-02341-2.
80. Searle BC. 2010. Scaffold: a bioinformatic tool for validating MS/MSbased proteomic studies. Proteomics 10:1265–1269. https://doi.org/10
.1002/pmic.200900437.
81. von Mering C, Huynen M, Jaeggi D, Schmidt S, Bork P, Snel B. 2003. STRING:
a database of predicted functional associations between proteins. Nucleic
Acids Res 31:258–261. https://doi.org/10.1093/nar/gkg034.

mbio.asm.org 19

Downloaded from http://mbio.asm.org/ on November 5, 2020 at Washington University in St. Louis

60. Zhang Y, Thery F, Wu NC, Luhmann EK, Dussurget O, Foecke M, Bredow C,
Jimenez-Fernandez D, Leandro K, Beling A, Knobeloch KP, Impens F, Cossart
P, Radoshevich L. 2019. The in vivo ISGylome links ISG15 to metabolic
pathways and autophagy upon Listeria monocytogenes infection. Nat Commun 10:5383. https://doi.org/10.1038/s41467-019-13393-x.
61. Ravenhill BJ, Boyle KB, von Muhlinen N, Ellison CJ, Masson GR, Otten EG,
Foeglein A, Williams R, Randow F. 2019. The cargo receptor NDP52
initiates selective autophagy by recruiting the ULK complex to cytosolinvading bacteria. Mol Cell 74:320 –329.e6. https://doi.org/10.1016/j
.molcel.2019.01.041.
62. Kwon DH, Song HK. 2018. A structural view of xenophagy, a battle
between host and microbes. Mol Cells 41:27–34. https://doi.org/10
.14348/molcells.2018.2274.
63. Huttlin EL, Ting L, Bruckner RJ, Gebreab F, Gygi MP, Szpyt J, Tam S,
Zarraga G, Colby G, Baltier K, Dong R, Guarani V, Vaites LP, Ordureau A,
Rad R, Erickson BK, Wuhr M, Chick J, Zhai B, Kolippakkam D, Mintseris J,
Obar RA, Harris T, Artavanis-Tsakonas S, Sowa ME, De Camilli P, Paulo JA,
Harper JW, Gygi SP. 2015. The BioPlex network: a systematic exploration
of the human interactome. Cell 162:425– 440. https://doi.org/10.1016/j
.cell.2015.06.043.
64. Baldanta S, Fernandez-Escobar M, Acin-Perez R, Albert M, Camafeita E,
Jorge I, Vazquez J, Enriquez JA, Guerra S. 2017. ISG15 governs mitochondrial function in macrophages following vaccinia virus infection. PLoS
Pathog 13:e1006651. https://doi.org/10.1371/journal.ppat.1006651.
65. Muniz-Feliciano L, Van Grol J, Portillo JA, Liew L, Liu B, Carlin CR,
Carruthers VB, Matthews S, Subauste CS. 2013. Toxoplasma gondiiinduced activation of EGFR prevents autophagy protein-mediated killing
of the parasite. PLoS Pathog 9:e1003809. https://doi.org/10.1371/journal
.ppat.1003809.
66. Nakashima H, Nguyen T, Goins WF, Chiocca EA. 2015. Interferonstimulated gene 15 (ISG15) and ISG15-linked proteins can associate with
members of the selective autophagic process, histone deacetylase 6
(HDAC6) and SQSTM1/p62. J Biol Chem 290:1485–1495. https://doi.org/
10.1074/jbc.M114.593871.
67. Xie X, Li F, Wang Y, Wang Y, Lin Z, Cheng X, Liu J, Chen C, Pan L. 2015.
Molecular basis of ubiquitin recognition by the autophagy receptor CALCOCO2. Autophagy 11:1775–1789. https://doi.org/10.1080/15548627.2015
.1082025.
68. Sasai M, Sakaguchi N, Ma JS, Nakamura S, Kawabata T, Bando H, Lee Y,
Saitoh T, Akira S, Iwasaki A, Standley DM, Yoshimori T, Yamamoto M.
2017. Essential role for GABARAP autophagy proteins in interferoninducible GTPase-mediated host defense. Nat Immunol 18:899 –910.
https://doi.org/10.1038/ni.3767.
69. Shpilka T, Weidberg H, Pietrokovski S, Elazar Z. 2011. Atg8: an
autophagy-related ubiquitin-like protein family. Genome Biol 12:226.
https://doi.org/10.1186/gb-2011-12-7-226.

